Watchman — Net Sales
Boston Scientific Watchman — Net Sales increased by 4.5% to $535.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 29.5%, from $413.00M to $535.00M. Over 4 years (FY 2021 to FY 2025), Watchman — Net Sales shows an upward trend with a 24.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market adoption and successful clinical penetration of the device, while a decrease may signal increased competition or market saturation.
Detailed definition
This metric represents the total revenue generated from the sale of left atrial appendage closure devices and related ac...
Peer comparison
Comparable to revenue metrics for specific high-growth interventional cardiology or structural heart franchises at peer medical device manufacturers.
bsx_segment_watchman_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $216.00M | $210.00M | $233.00M | $226.00M | $250.00M | $262.00M | $281.00M | $291.00M | $317.00M | $323.00M | $343.00M | $344.00M | $379.00M | $380.00M | $413.00M | $425.00M | $486.00M | $512.00M | $535.00M |
| QoQ Change | — | -2.8% | +11.0% | -3.0% | +10.6% | +4.8% | +7.3% | +3.6% | +8.9% | +1.9% | +6.2% | +0.3% | +10.2% | +0.3% | +8.7% | +2.9% | +14.4% | +5.3% | +4.5% |
| YoY Change | — | — | — | — | +15.7% | +24.8% | +20.6% | +28.8% | +26.8% | +23.3% | +22.1% | +18.2% | +19.6% | +17.6% | +20.4% | +23.5% | +28.2% | +34.7% | +29.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's watchman — net sales?
- Boston Scientific (BSX) reported watchman — net sales of $535.00M in Q4 2025.
- How has Boston Scientific's watchman — net sales changed year-over-year?
- Boston Scientific's watchman — net sales increased by 29.5% year-over-year, from $413.00M to $535.00M.
- What is the long-term trend for Boston Scientific's watchman — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's watchman — net sales has grown at a 24.0% compound annual growth rate (CAGR), from $829.00M to $1.96B.
- What does watchman — net sales mean?
- Total revenue generated from the sales of the company's left atrial appendage closure medical device product line.